NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 194 filers reported holding NOVAVAX INC in Q2 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2016 | $61,000 | +41.9% | 8,400 | 0.0% | 0.00% | – |
| Q1 2016 | $43,000 | -96.1% | 8,400 | -93.7% | 0.00% | -100.0% |
| Q4 2015 | $1,113,000 | +4.3% | 132,700 | -12.1% | 0.01% | 0.0% |
| Q3 2015 | $1,067,000 | -35.5% | 151,000 | +1.6% | 0.01% | -28.6% |
| Q2 2015 | $1,655,000 | +29.7% | 148,600 | -3.8% | 0.01% | +16.7% |
| Q1 2015 | $1,276,000 | +16.1% | 154,400 | -16.7% | 0.01% | +20.0% |
| Q4 2014 | $1,099,000 | -28.9% | 185,300 | -50.0% | 0.01% | +25.0% |
| Q3 2014 | $1,546,000 | +72.9% | 370,600 | +91.6% | 0.00% | 0.0% |
| Q2 2014 | $894,000 | +12.2% | 193,400 | +9.9% | 0.00% | 0.0% |
| Q1 2014 | $797,000 | -9.6% | 175,900 | +2.1% | 0.00% | 0.0% |
| Q4 2013 | $882,000 | +45.3% | 172,300 | -10.4% | 0.00% | +33.3% |
| Q3 2013 | $607,000 | – | 192,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |